Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - Lung cancer, 2008 - Elsevier
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …
被引用次数：44 相关文章

[引用][C] Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A BEARZ, I GARASSINO, U TIRELLI, R CAVINA… - Lung …, 2008 - pascal-francis.inist.fr
Pemetrexed single agent in previously treated non-small cell lung cancer : A multi-institutional
observational study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - LUNG CANCER, 2008 - iris.unime.it
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

A Bearz, I Garassino, R Cavina, A Favaretto… - Lung Cancer …, 2007 - europepmc.org
Results One hundred and sixty patients from 4 different Italian Institutions, treated with
Pemetrexed, mostly as second-line therapy, were analysed. There was a predominance of …
[PDF] academia.edu

[PDF][PDF] Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearza, I Garassinob, R Cavinab, A Favarettoc… - Lung …, 2008 - academia.edu
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study

A Bearz, I Garassino, R Cavina… - Lung cancer …, 2008 - pubmed.ncbi.nlm.nih.gov
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …

Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - LUNG …, 2008 - iris.hunimed.eu
Several drugs have been approved for the treatment of patients affected by advanced non-
small. cell tung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …

Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - Lung Cancer, 2008 - infona.pl
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …

Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - Lung …, 2008 - lungcancerjournal.info
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …
[PDF] researchgate.net

[PDF][PDF] Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

A Bearz, I Garassino, R Cavina, A Favaretto… - Lung …, 2008 - researchgate.net
Several drugs have been approved for the treatment of patients affected by advanced non-
small cell lung cancer (NSCLC) in progression after first line chemotherapy: Docetaxel …